Tag: multiparametric MRI

Artificial Intelligence is reshaping prostate cancer care, from more accurate screening and early detection to optimizing treatment strategies. New research highlights four major clinical areas where AI is already making a measurable difference in diagnosis, risk assessment, and therapy planning. keep reading

Researchers are questioning if PSMA-PET scans, usually reserved for advanced prostate cancer, might offer added value when used alongside mpMRI earlier in diagnosis. Studies suggest a combined approach could improve detection, but questions remain about cost, accuracy, and future role. keep reading

Recent studies reveal the digital rectal exam may not improve early prostate cancer detection compared to PSA testing. As experts question its usefulness, advanced tools like multiparametric MRI are shaping modern screening guidelines. keep reading

New research asks if healthy lifestyle choices—like diet, supplements, and exercise—can slow the growth of low-risk prostate cancer during active surveillance. While results remain inconclusive, promising signs exist, and minimally invasive focal therapy is emerging as an alternative option. keep reading

Multiparametric MRI uses advanced imaging sequences to identify suspicious prostate tissue, clarify abnormal PSA results, and help avoid unnecessary biopsies. This noninvasive approach is changing the standard for early and accurate prostate cancer diagnosis. keep reading

Experts outline a 10-step process that enhances the accuracy of focal therapy for prostate cancer, using detailed MRI imaging, calculated safety margins, and thoughtful selection of treatment methods. The framework aims to maximize tumor control while minimizing side effects. keep reading

What if knowing everything about your prostate wasn’t just about high-tech scans, but also about someone truly hearing what matters most? Empathic listening and attention to personal values at Sperling Prostate Center set the stage for more informed, satisfying choices in prostate care. keep reading

Can a cancer diagnosis bring a sense of relief? For men with prostate cancer caught at Grade Group 1, emerging research and expert protocols suggest that aggressive treatments can often be avoided. Active surveillance, targeted focal therapies, and more precise diagnostic tools are helping many choose paths that spare quality of life. keep reading

Recent research uncovers substantial agreement between MRI-targeted prostate biopsy results and surgical specimens, offering fresh insight into biopsy accuracy for prostate cancer. Rates of concordance are highest for more aggressive disease, yet lower for lower-grade findings. keep reading